Datascope Corp. (NASDAQ: DSCP) today reported net earnings for fiscal 2006 of $25.8 million, or $1.69 per diluted share, compared with $14.6 million, or 97 cents per diluted share, for fiscal 2005. Earnings in fiscal 2006 included a special dividend of $3.9 million after tax, or 26 cents per diluted share, paid out by a company in which we have an investment, a gain of $0.8 million after tax, or 5 cents per diluted share, from the sale of an unused facility, and a charge of $1.8 million after tax, or 12 cents per diluted share, related to the postponement of the launch of the X-Site® vascular closure device. Net earnings in fiscal 2005 included charges of $4.8 million after tax, or 32 cents per diluted share, related to write-downs of investments in two medical technology companies, discontinued development projects and severance charges, and a one-time income tax expense of $2.0 million, or 13 cents per diluted share, related to the repatriation of $30 million of foreign earnings.